Curi RMB Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $559K | Buy |
1,256
+835
| +198% | +$372K | 0.01% | 494 |
|
|
2025
Q1 | $204K | Sell |
421
-1,289
| -75% | -$625K | 0.01% | 467 |
|
|
2024
Q4 | $689K | Buy |
1,710
+130
| +8% | +$52.4K | 0.02% | 376 |
|
|
2024
Q3 | $735K | Buy |
1,580
+71
| +5% | +$33K | 0.02% | 381 |
|
|
2024
Q2 | $707K | Buy |
1,509
+319
| +27% | +$150K | 0.02% | 372 |
|
|
2024
Q1 | $497K | Buy |
1,190
+11
| +0.9% | +$4.6K | 0.01% | 433 |
|
|
2023
Q4 | $480K | Buy |
1,179
+56
| +5% | +$22.8K | 0.01% | 388 |
|
|
2023
Q3 | $391K | Buy |
1,123
+117
| +12% | +$40.7K | 0.01% | 398 |
|
|
2023
Q2 | $354K | Buy |
1,006
+11
| +1% | +$3.87K | 0.01% | 412 |
|
|
2023
Q1 | $313K | Hold |
995
| – | – | 0.01% | 420 |
|
|
2022
Q4 | $287K | Buy |
+995
| New | +$287K | 0.01% | 423 |
|
|
2020
Q4 | – | Sell |
-1,167
| Closed | -$318K | – | 639 |
|
|
2020
Q3 | $318K | Sell |
1,167
-212
| -15% | -$57.8K | 0.01% | 485 |
|
|
2020
Q2 | $400K | Buy |
1,379
+176
| +15% | +$51.1K | 0.02% | 436 |
|
|
2020
Q1 | $286K | Sell |
1,203
-7,994
| -87% | -$1.9M | 0.01% | 495 |
|
|
2019
Q4 | $2.01M | Buy |
9,197
+1,610
| +21% | +$353K | 0.06% | 261 |
|
|
2019
Q3 | $1.29M | Sell |
7,587
-6,685
| -47% | -$1.13M | 0.03% | 337 |
|
|
2019
Q2 | $2.62M | Sell |
14,272
-831
| -6% | -$152K | 0.07% | 245 |
|
|
2019
Q1 | $2.78M | Sell |
15,103
-6,010
| -28% | -$1.11M | 0.07% | 254 |
|
|
2018
Q4 | $3.5M | Buy |
21,113
+617
| +3% | +$102K | 0.09% | 210 |
|
|
2018
Q3 | $3.95M | Buy |
20,496
+5,032
| +33% | +$970K | 0.09% | 210 |
|
|
2018
Q2 | $2.63M | Sell |
15,464
-6,308
| -29% | -$1.07M | 0.06% | 297 |
|
|
2018
Q1 | $3.55M | Buy |
+21,772
| New | +$3.55M | 0.09% | 254 |
|